SCHEMBL13850489

SCHEMBL13850489

CNC(=O)C(Cc1ccc(O)cc1)NC(=O)/C=C/c1ccccc1

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GRIA1 P42261 1/20 0.63
NOS2 P35228 6/20 0.59
PPARG P37231 1/20 0.56
EED O75530 1/20 0.54
NOS3 P29474 3/20 0.54
NOS1 P29475 3/20 0.54
MMP9 P14780 5/20 0.52
MMP1 P03956 5/20 0.52
MMP2 P08253 3/20 0.52
DEGS1 O15121 1/20 0.52
MMP8 P22894 2/20 0.50
MAOA P21397 1/20 0.49
MAOB P27338 1/20 0.49
FCER2 P06734 1/20 0.49
ALDH1A1 P00352 1/20 0.49
CYP1A2 P05177 1/20 0.49
CYP3A4 P08684 1/20 0.49
CYP2C9 P11712 1/20 0.49
MAPK1 P28482 1/20 0.49
CYP2C19 P33261 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1558517 0.87 NOS2 (0.75) GRIA1NOS2PPARGNOS3NOS1
SCHEMBL1558521 0.87 NOS2 (0.75) GRIA1NOS2PPARGNOS3NOS1
SCHEMBL1558519 0.87 NOS2 (0.75) GRIA1NOS2PPARGNOS3NOS1
SCHEMBL1711193 0.85 NOS2 (0.73) GRIA1NOS2PPARGNOS3NOS1
SCHEMBL21996039 0.82 NOS2 (0.75) GRIA1NOS2PPARGNOS3NOS1
SCHEMBL21996040 0.82 NOS2 (0.75) GRIA1NOS2PPARGNOS3NOS1
SCHEMBL21996042 0.82 NOS2 (0.75) GRIA1NOS2PPARGNOS3NOS1
SCHEMBL3168224 0.82 NOS2 (0.67) GRIA1NOS2PPARGNOS3NOS1
SCHEMBL28965792 0.82 NOS2 (0.67) GRIA1NOS2PPARGNOS3NOS1
SCHEMBL1711585 0.82 NOS2 (0.67) GRIA1NOS2PPARGNOS3NOS1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090124690-A1 Generation of Combinatorial Synthetic Libraries and Screening for Novel Proadhesins and Nonadhesins CERNOFINA, LLC 2009-05-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090124690-A1 Generation of Combinatorial Synthetic Libraries and Screening for Novel Proadhesins and Nonadhesins SELP, SELE, SELPLG GRIA1 3301/4885NOS2 1883/4885PPARG 1837/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.